Estimated Conjunctivitis-Related Healthcare Cost Savings With Increased Tralokinumab Use Versus Other Biologics Among Patients With Moderate-Severe Atopic Dermatitis in the United States. J of Skin 2025, 9 (6), s630. https://doi.org/10.25251/ej4zcr36.